Tarbox Family Office’s GSK GSK Stock Holding History

Tarbox Family Office’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-8	Closed	-$398	–	584
2015 Q4	$0	Hold	8	–	–	﹤0.01%	557
2015 Q3	$0	Buy	+8	New	+$416	﹤0.01%	570

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Tarbox Family Office's GSK Position: Q1 2016 in Review

Tarbox Family Office sold out of GSK (GSK) in Q1 2016, closing a stake of 8 shares — an estimated $398 sold.

Tarbox Family Office first reported a position in GSK in Q3 2015 and held it in 2 quarters. The position peaked at $0 in Q4 2015. 726 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

Tarbox Family Office reported no remaining GSK position as of Q1 2016 after selling out during the quarter.
Tarbox Family Office sold 8 GSK shares in Q1 2016, an estimated $398.
Tarbox Family Office first reported a position in GSK in Q3 2015 and held it in 2 quarters.
Tarbox Family Office's GSK position peaked at $0 in Q4 2015.
726 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on Tarbox Family Office's 13F filing for Q1 2016, filed 27 Apr 2016.